Class / Patent application number | Description | Number of patent applications / Date published |
424678000 | Calcium chloride | 24 |
20090011050 | Skin Treatment Composition And Method - Disclosed is a composition which is provided as a cream. One use for the product is for removing urushiol oil from the dermal layer of the skin using a combination of other oils. The composition may include all or some of Apricot oil (kernel oil), Avocado oil, Dead Sea Salts, Eucalyptus (essential oil), Grapefruit oil (pink, essential oil), Grapeseed oil (essential oil), Jojoba oil (organic), Lemon oil (essential oil), Orange oil juicy flavor oil), Peppermint (essential oil), Rosemary oil (essential oil), Spearmint oil (essential oil), Vitamin E oil (T-50 all natural); and Walnut oil. | 01-08-2009 |
20090263506 | CALCAREOUS ORGANISM GROWTH ACCELERATOR - The purpose of this invention is to provide compositions useful for promoting the growth of calcareous organisms present in a closed system aquatic habitat. Particularly, to composition capable of efficiently delivering calcium and carbonate to the calcareous organisms. Most particularly, to a composition effective for enhanced delivery of aragonite to a closed system aquatic habitat where it dissociates into bioavailable supplements, such as, calcium, strontium, magnesium, and carbonate ions, whereby enhanced growth of the calcareous organisms is achieved. | 10-22-2009 |
20100104663 | REHYDRATION COMPOSITION FOR PREPARING A SOLUTE BY RECONSTITUTION IN WATER - The present invention relates to a rehydration composition intended for the preparation of a solution by reconstitution in water, preferably slightly mineralized water. | 04-29-2010 |
20100151054 | EMULSION LOTION - An emulsion lotion composition including
| 06-17-2010 |
20100233295 | AQUEOUS MOISTURIZERS AND LUBRICANTS AND USES THEREOF - This application relates to water-based personal moisturizers and lubricants that relive vaginal dryness. These compositions are non-spermicidal, sperm- and egg-friendly, and in various embodiments may mimic biological fluids, enhance sperm survival and motility, promote binding of sperm to eggs, and/or facilitate the process of fertilization. Related articles, systems, and methods of preparation and use of the compositions are also provided. | 09-16-2010 |
20110165267 | AGENTS FOR TREATING AND/OR AVOIDING FIRE BLIGHT - The invention relates to agents for treating and/or avoiding fire blight in plants of the Rosaceae, in particular of the subfamilies Maloideae and Rosoideae, containing formiates as the active component. | 07-07-2011 |
20120034320 | Skin Penetration Composition - The present invention comprises an all-natural composition of matter and methods of delivering nutrients, medicines, pain relievers, antioxidants, antidotes, antibiotics and various active ingredients and supplements directly to the affected area of the body. The all-natural carrier composition consists essentially of the combination of a natural oil, water, salt(s), natural emulsifier, natural sugar(s), plant extracts, natural acid(s), starch and natural flavor(s). The active substances that are mixed with the all-natural carrier composition, include, but are not limited to, drugs, vitamins, minerals, antibiotics anti fungal agents, antioxidants, diuretics, allergy medicines, anti-inflammatory agents, muscle relaxers, pain reducers, diabetic drugs, neuropathy drugs, chemotherapy agents, arthritis drugs, lotions for eczema, shingles, psoriasis, skin rash; herbal medicines, erectile dysfunction drugs, hormones, cholesterol drugs, essential fatty acids, and the like. The all-natural carrier composition facilitates the penetration of active substances into the dermal layer of the skin. | 02-09-2012 |
20120064178 | Cell-8 Solution - Cell-8 Solution is an intravenous solution introduced into the veins of the patient. Cell-8 Solution provides the cells of the body with highly absorbed minerals as well as new RNA information which changes the relationship of the body to the cancer in question. Treatment with Cell-8 Solution will prevent the body from accepting the existence of cancer cells so that cancer cell replication will no longer occur. Although intravenous Cell-8 Solution is superior, other applications include nebulized, transdermal and oral. | 03-15-2012 |
20120288572 | MULTICHAMBER CONTAINER FOR PREPARING MEDICINAL SOLUTIONS - The subject matter of the present invention is a multichamber container and a method for preparing medical fluids composed of concentrates which make a contribution toward the electrical conductivity of the solution and are additionally prepared from concentrates which do not make a contribution toward the electrical conductivity of the solution. The inventive multichamber container is characterized in that it is constructed by dividing the solution components into multiple chambers, so that following the dissolving due to breaking open of the first chamber border of a solution component, which makes a contribution toward the electrical conductivity of the medicinal solution, another chamber border of another solution component which does not make any contribution toward the electrical conductivity of the solution is broken open. | 11-15-2012 |
20130004593 | CONTAINER, USE, DIALYZER OR PREPARATION UNIT AS WELL AS METHOD OF MANUFACTURING A CONCENTRATE - The present invention relates to a container comprising at least a dry concentrate, wherein the dry concentrate is designed such that it forms at least one acid liquid concentrate, or a part of an acid liquid concentrate, which is suitable for manufacturing at least on dialysis solution, on its dissolving in a liquid, preferably in water. | 01-03-2013 |
20130183389 | DIALYSIS PRECURSOR COMPOSITION - The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consist of powder components comprising sodium chloride, at least one dry acid and at least one magnesium salt, and optionally potassium salt, calcium salt, and glucose. According to the invention said at least one magnesium salt and said optional glucose, are present as anhydrous components in said dialysis acid precursor composition. | 07-18-2013 |
20130189376 | DIALYSIS PRECURSOR COMPOSITION - The present invention concerns a dialysis acid precursor composition for use during preparation of a dialysis acid concentrate solution and for mixing with water, a sodium containing concentrate, and a bicarbonate containing concentrate into a ready-for-use dialysis solution. Said dialysis acid precursor composition consists of powder components comprising glucose, at least one dry acid and at least one magnesium salt, and optionally potassium salt, and calcium salt. According to the invention said glucose and said at least one magnesium salt, are present as anhydrous components in said dialysis acid precursor composition. | 07-25-2013 |
20130236571 | Dispersions in Oil of Dead Sea Nano Sized Material Preparation and Uses Therof - The present disclosure is directed to dispersions of a Dead Sea material in oil, the Dead Sea material is present in the dispersions in the form of solid nanoparticles. Further disclosed are formulations comprising the dispersions, method of treating and/or preventing diseases or disorders of the skin comprising topical application of the dispersions or formulations thereof onto a skin of a subject, method of inducing a heat sensation on the skin of a subject by topically applying the dispersions or formulations thereof onto a skin of a subject and methods of preparing the dispersions. | 09-12-2013 |
20130344171 | ACIDIC DIALYSIS CONCENTRATE - The precursor of an acidic dialysis concentrate is characterized in that two separately provided partial concentrates are formed from the constituents of the acidic dialysis concentrate, wherein only the one partial concentrate contains glucose, preferably glucose monohydrate, while the other partial concentrate comprises other constituents needed for the acidic dialysis concentrate. | 12-26-2013 |
20140212513 | TOPICAL COMPOSITIONS COMPRISING DEAD SEA WATER AND USES THEREOF - The present disclosure provides method of inducing secretion of beta-endorphin in a skin region of a subject, the method comprises topically applying a composition comprising at least 0.5% Dead Sea Water onto a skin region of a subject. The disclosure further provides a method of modifying at least one condition of a skin region of a subject, the method comprises topically applying a composition comprising at least 0.5% Dead Sea Water onto the skin region of the subject, wherein the at least one skin condition is selected from the group consisting of mechanical and physiological skin condition and wherein the modifying of the at least one skin condition is associated with induction of skin beta-endorphin secretion in the skin region. | 07-31-2014 |
20140322359 | HUMAN HOMEOBOX GENE VENTX AND MACROPHAGE TERMINAL DIFFERENTIATION AND ACTIVATION, COMPOSITIONS AND METHODS THEREOF - The invention relates to a unique formulated pharmaceutical composition and a novel treatment method of intratumoral injection. The pharmaceutical composition of the invention is the saturated ionic solution of sodium ions and calcium ions (the “medicinal ion bomb”). The invention of intratumoral injection with the “medicinal ion bomb” can be used as the first-line treatment in treating cancer and tumor in nine human organs (carcinoma and tumor of the skin and subcutaneous tissue, breast, prostate, thyroid, lung, liver, genital organ, brain and pancreas) and certain other benign diseases (skin and subcutaneous neoplasm, breast fibrocystic change, benign prostatic hyperplasia and thyroid nodules). | 10-30-2014 |
20140328948 | BUFFERED COMPOSITIONS FOR DIALYSIS - Acid concentrates, and dialysate compositions prepared therefrom, contain citric acid and an effective amount of a buffering agent selected from acetate and/or lactate. The buffering agent allows a physiologically acceptable amount of citrate to maintain the desired pH of the dialysate. | 11-06-2014 |
20140363524 | DIALYSIS PRECURSOR COMPOSITION - A dialysis acid precursor assembly including a dialysis acid precursor composition of dry components including anhydrous glucose, a dry acid, a magnesium chloride 4.5-hydrate (MgCl | 12-11-2014 |
20150313858 | DIALYSIS COMPOSITION - The present invention relates to an acid concentrate dialysis composition an acid concentrate dialysis composition comprising a mixture of citric acid and citrate, having pH of less than 3.0, wherein the total concentration of citrate is between 35 mM and 450 mM, and wherein the amount of citric acid is more than 50% of the total concentration of citrate. The acid concentrate dialysis composition is to be combined to form a dialysis solution having a total concentration of citrate of between 1 and 6 mM. | 11-05-2015 |
20150330995 | MCAM AS A BIOMARKER FOR FLUID HOMEOSTASIS - The application discloses MCAM as a new biomarker for fluid homeostatic imbalance; methods for predicting, diagnosing, prognosticating and/or monitoring fluid homeostatic imbalance based on measuring said biomarker; and kits and devices for measuring said biomarker and/or performing said methods. | 11-19-2015 |
20150342986 | COMPOSITIONS AND METHODS FOR PAIN RELIEF WITHOUT NUMBNESS - Methods for providing post-operative pain control or relief, without a medically significant degree of numbness, to a patient are disclosed. Methods include, for example, administering bicarbonate to an area of a patient during a surgical or dental procedure, near completion of a surgical or dental procedure or immediately following a surgical or dental procedure, in an area previously administered or containing a regional or local anesthetic, in an amount sufficient to provide the patient with pain control or relief, without a medically significant degree of numbness, for a period of time after the surgical or dental procedure. | 12-03-2015 |
20150352049 | PHARMACEUTICAL COMPOSITION FOR PROTECTING WOUNDS, PROVIDING HEMOSTASIS, OR PREVENTING ADHESION IN THE GASTROINTESTINAL TRACT - The present invention provides a pharmaceutical composition in a powder form for providing wound protection, hemostasis, or anti-adhesion in the gastrointestinal tract, which comprises a certain mucoadhesive polymer; and a certain hygroscopic agent. | 12-10-2015 |
20160051583 | METHOD AND COMPOSITION FOR THE TREATMENT OF SKIN CONDITIONS - The present invention relates to artificial seawater and its use to treat a variety of skin conditions, when that seawater has more magnesium in it than in naturally occurring seawater. The treatment of acne and the like can be improved with the product of the present invention. | 02-25-2016 |
20160184350 | DIALYSIS PRECURSOR COMPOSITION - A dialysis acid precursor assembly including: a dry dialysis acid precursor composition including sodium chloride, a dry acid and a magnesium chloride 4.5-hydrate (MgCl2.4.5H2O), a calcium salt and at least one of a potassium salt, calcium salt and an anhydrous glucose, and a moisture-resistant container having a water vapor transmission rate less than 0.2 g/m2/d at 38° C./90% RH, wherein the dry dialysis acid precursor composition is sealed in the container. | 06-30-2016 |